These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 36215877

  • 1. Validation and application of a quantitative LC-MS/MS assay for the analysis of first-line anti-tuberculosis drugs, rifabutin and their metabolites in human breast milk.
    Zuma P, Joubert A, van der Merwe M, Norman J, Waitt C, Court R, Loveday M, Castel S, Wiesner L.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Nov 15; 1211():123489. PubMed ID: 36215877
    [Abstract] [Full Text] [Related]

  • 2. Rapid and highly sensitive quantification of the anti-tuberculosis agents isoniazid, ethambutol, pyrazinamide, rifampicin and rifabutin in human plasma by UPLC-MS/MS.
    Wu L, Ye Z, Liu H, Guo H, Lin J, Zheng L, Chu N, Liu X.
    J Pharm Biomed Anal; 2020 Feb 20; 180():113076. PubMed ID: 31896523
    [Abstract] [Full Text] [Related]

  • 3. A battery of tandem mass spectrometry assays with stable isotope-dilution for the quantification of 15 anti-tuberculosis drugs and two metabolites in patients with susceptible-, multidrug-resistant- and extensively drug-resistant tuberculosis.
    Mercier T, Desfontaine V, Cruchon S, Da Silva Pereira Clara JA, Briki M, Mazza-Stalder J, Kajkus A, Burger R, Suttels V, Buclin T, Opota O, Koehler N, Sanchez Carballo PM, Lange C, André P, Decosterd LA, Choong E.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Nov 15; 1211():123456. PubMed ID: 36240540
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A high-throughput LC-MS/MS method for simultaneous determination of isoniazid, ethambutol and pyrazinamide in human plasma.
    Pršo K, Žideková N, Porvazník I, Solovič I, Mokrý J, Kertys M.
    Rapid Commun Mass Spectrom; 2023 Jan 30; 37(2):e9425. PubMed ID: 36329637
    [Abstract] [Full Text] [Related]

  • 7. LC-QToF-MS method for quantification of ethambutol, isoniazid, pyrazinamide and rifampicin in human plasma and its application.
    Fachi MM, Vilhena RO, Boger B, Domingos EL, Dos Santos JMMF, Junkert AM, de Fátima Cobre A, Momade DRO, Beraldi-Magalhães F, de Liz MV, Cordeiro-Santos M, Pontarolo R.
    Biomed Chromatogr; 2020 May 30; 34(5):e4812. PubMed ID: 32068899
    [Abstract] [Full Text] [Related]

  • 8. Development, validation and clinical use of a LC-MS/MS method for the simultaneous determination of the nine main antituberculosis drugs in human plasma.
    Fage D, Brilleman R, Deprez G, Payen MC, Cotton F.
    J Pharm Biomed Anal; 2022 Jun 05; 215():114776. PubMed ID: 35462286
    [Abstract] [Full Text] [Related]

  • 9. Standardization and validation of a novel UPLC-MS/MS method to quantify first line anti-tuberculosis drugs in plasma and dried blood spots.
    Herrera-Pérez IG, Rodríguez-Báez AS, Ortiz-Álvarez A, Velarde-Salcedo R, Arriaga-García FJ, Rodríguez-Pinal CJ, Romano-Moreno S, Milán-Segovia RDC, Medellín-Garibay SE.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Aug 01; 1228():123801. PubMed ID: 37453389
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee.
    J Assoc Physicians India; 2006 Mar 01; 54():219-34. PubMed ID: 16800350
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Diagnostic accuracy of a liquid chromatography-tandem mass spectrometry assay in small hair samples for rifampin-resistant tuberculosis drug concentrations in a routine care setting.
    Metcalfe J, Bacchetti P, Esmail A, Reckers A, Aguilar D, Wen A, Huo S, Muyindike WR, Hahn JA, Dheda K, Gandhi M, Gerona R.
    BMC Infect Dis; 2021 Jan 22; 21(1):99. PubMed ID: 33482745
    [Abstract] [Full Text] [Related]

  • 16. Simultaneous determination of first-line anti-tuberculosis drugs and their major metabolic ratios by liquid chromatography/tandem mass spectrometry.
    Song SH, Jun SH, Park KU, Yoon Y, Lee JH, Kim JQ, Song J.
    Rapid Commun Mass Spectrom; 2007 Jan 22; 21(7):1331-8. PubMed ID: 17340570
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Development and validation of a hydrophilic interaction liquid chromatography-tandem mass spectrometry method for the simultaneous determination of five first-line antituberculosis drugs in plasma.
    Zhou Z, Wu X, Wei Q, Liu Y, Liu P, Ma A, Zou F.
    Anal Bioanal Chem; 2013 Jul 22; 405(19):6323-35. PubMed ID: 23719934
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.